An Observational Study Examining the Use of Triple Combination Therapy With Boceprevir, Peginterferon Alfa-2a and Ribavirin in the Re-Treatment of Chronic Hepatitis C Patients

Clinical trial NCT02118597 · TERMINATED

Trial details

NCT number: NCT02118597
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Study type: OBSERVATIONAL

Hepatitis C, Chronic

Start date: 2014-05-01
Primary completion: 2015-05-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.